4ª Edição

Nivolumab has a positive impact on overall survival in patients with refractory esophageal cancer

por: Oncoclínicas
Nivolumab has a positive impact on overall survival in patients with refractory esophageal cancer

Comissão científica

Alexandre Jácome
Alexandre Jácome
Alexandre Palladino
Alexandre Palladino
Gabriel Prolla
Gabriel Prolla
Roberto Gil
Roberto Gil

Colaboradores

Cintia Elaine Nascimento Givigi
Cintia Elaine Nascimento Givigi
Rafael José Vargas Alves
Rafael José Vargas Alves

This is a scientific newsletter curated by the main medical-scientific content for each specialty and interdisciplinary work between oncology and other areas. Enjoy your reading!

Acesse o artigo completo deste estudo
Download
Compartilhe
Ou compartilhe o link
Link copiado para sua área de trabalho.L